The FDA (US Food and Drug Administration) is allowing temporary flexibility in food labelling requirements for manufacturers experiencing difficulty sourcing some ingredients during the COVID-19 pandemic. It has published temporary guidance to allow for minor formulation changes without updating labels, in order to help minimise the impact of supply chain disruptions associated with the current COVID-19 pandemic on product availability.
Read the article here
Comments